Registry Study for Proton Therapy Outcomes

This study is currently recruiting participants.
Verified February 2014 by Proton Collaborative Group
Sponsor:
Information provided by (Responsible Party):
Proton Collaborative Group
ClinicalTrials.gov Identifier:
NCT01255748
First received: December 6, 2010
Last updated: February 19, 2014
Last verified: February 2014
  Purpose

The purpose of this research study is to collect and analyze information from patients being treated with proton therapy.


Condition Intervention
Solid Tumors
Radiation: Proton Therapy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Proton Therapy

Resource links provided by NLM:


Further study details as provided by Proton Collaborative Group:

Primary Outcome Measures:
  • Define outcomes for patients treated at participating institutions [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [ Time Frame: Annually PRN ] [ Designated as safety issue: Yes ]
  • Improve patient care by an adequate understanding of the results and patient population at participating institutions [ Time Frame: Reviewed Annually PRN ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: June 2009
Groups/Cohorts Assigned Interventions
Treatment with Proton Therapy Radiation: Proton Therapy
Outcomes Tracking

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Primary care clinic

Criteria

Inclusion Criteria:

  • Planned treatment with proton radiation
  • Ability to understand and sign IRB approved consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01255748

Contacts
Contact: Megan Dunn, PhD,MSHS 630-657-0092 mdunn@pcgresearch.org

Locations
United States, Illinois
CDH Proton Center Recruiting
Warrenville, Illinois, United States, 60555
Contact: Corey Woods, RN    630-821-6397    corey.woods@chi.procure.com   
Principal Investigator: William Hartsell, MD         
United States, New Jersey
ProCure Proton Therapy Center Recruiting
Somerset, New Jersey, United States, 08873
Contact: Carl Brown    732-357-2676    carl.brown@nj.procure.com   
Principal Investigator: Brian Chon, MD         
United States, Oklahoma
ProCure Proton Therapy Center Recruiting
Oklahoma City, Oklahoma, United States, 73142
Contact: Tisha Adams, MS,CCRC    405-773-6775    tisha.adams@okc.procure.com   
Principal Investigator: Gary Larson, MD         
United States, Washington
University of Washington Recruiting
Seattle, Washington, United States, 98195-6043
Contact: Jennifer Revall    206-598-8629    jrevall@uw.edu   
Principal Investigator: George Laramore, MD         
Sponsors and Collaborators
Proton Collaborative Group
Investigators
Study Chair: Carlos Vargas, MD Proton Collaborative Group
  More Information

No publications provided

Responsible Party: Proton Collaborative Group
ClinicalTrials.gov Identifier: NCT01255748     History of Changes
Other Study ID Numbers: REG001-09
Study First Received: December 6, 2010
Last Updated: February 19, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Proton Collaborative Group:
cancer, proton, radiation

ClinicalTrials.gov processed this record on April 16, 2014